POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,204 | -23.7% | 45,158 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $394,590 | +29.5% | 43,553 | +4.0% | 0.00% | 0.0% |
| Q1 2023 | $304,598 | +3.3% | 41,898 | +3.6% | 0.00% | 0.0% |
| Q4 2022 | $294,764 | +8.4% | 40,434 | +15.0% | 0.00% | 0.0% |
| Q3 2022 | $272,000 | +15.3% | 35,158 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $236,000 | – | 34,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,560,984 | $27,526,000 | 6.63% |
| Fairmount Funds Management LLC | 2,833,950 | $21,906,000 | 3.85% |
| JOHNSON & JOHNSON | 1,000,000 | $7,730,000 | 2.28% |
| BVF INC/IL | 5,590,048 | $43,211,000 | 1.78% |
| Affinity Asset Advisors, LLC | 746,576 | $5,771,000 | 1.61% |
| Sio Capital Management, LLC | 544,545 | $4,209,000 | 1.34% |
| PFM Health Sciences, LP | 4,515,216 | $34,903,000 | 1.26% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,052,842 | $8,138,000 | 1.13% |
| Boxer Capital, LLC | 2,500,000 | $19,325,000 | 1.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $2,319,000 | 0.78% |